NYSTATIN
Generic: NYSTATIN
Major PharmaceuticalsManufacturer
ORALRoute
NYSTATINActive Substance
2016-01-07Original Approval
NYSTATIN is FDA application ANDA203621, sponsored by PHARM ASSOC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2017-03-28
Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributeFailed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability
Class II2021-07-29
Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL)Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class II2026-06-23
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, IsrSubpotent Drug: Low out of specification assay results performed during long-term stability testing.
Class III2019-07-17
Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin PharmacFailed Content Uniformity Specifications: Out-of-specification result observed in uniformity of cont
Top Reported Reactions
1
NAUSEA
2,027 reports
2
FATIGUE
1,796 reports
3
DIARRHOEA
1,794 reports
4
PNEUMONIA
1,646 reports
5
DYSPNOEA
1,490 reports
6
OFF LABEL USE
1,482 reports
7
VOMITING
1,399 reports
8
DRUG INEFFECTIVE
1,299 reports
9
PAIN
1,234 reports
10
DEATH
1,155 reports